29.16
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Viking Therapeutics (VKTX) Sees Unusual Options Activity | VKTX Stock News - GuruFocus
Why Viking Therapeutics Stock Was Victorious This Week - MSN
(VKTX) Investment Report - news.stocktradersdaily.com
Viking Therapeutics (VKTX) Sees 20% Stock Surge Despite Financial Losses - GuruFocus
Why Viking Therapeutics (VKTX) Stock is Rising Today - GuruFocus
Viking Therapeutics call volume above normal and directionally bullish - TipRanks
Viking Therapeutics (VKTX) Sees Surge in Call Options Trading | VKTX Stock News - GuruFocus
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 - simplywall.st
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday - The Globe and Mail
This Soaring Stock Just Delivered More Good News. Time to Buy? - AOL.com
Where Will Viking Therapeutics Be in 3 Years? - Yahoo Finance
1 Beaten-Down Stock to Buy and Hold for 10 Years - Nasdaq
BlackRock, Inc. Reduces Stake in Viking Therapeutics Inc - GuruFocus
Viking Therapeutics (VKTX) Sees Boost After Pfizer's Acquisition Plans - GuruFocus
Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? - Yahoo Finance
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain - Nasdaq
Viking stock rises as Pfizer ups deal prospects (VKTX:NASDAQ) - Seeking Alpha
Why Viking Therapeutics Stock Popped Again Today - MSN
VKTX Stock Surges Amid Analyst Optimism on VK2735 - GuruFocus
Cantor Fitzgerald starts Viking Therapeutics stock with Overweight By Investing.com - Investing.com India
Cantor Fitzgerald starts Viking Therapeutics stock with Overweight - Investing.com
Cantor Fitzgerald initiated coverage on Viking Therapeutics with a new price target - Quantisnow
Why Viking Therapeutics (VKTX) Stock is On the Move - GuruFocus
Viking Therapeutics (VKTX) Sees Stock Rise Despite Increased Los - GuruFocus
Viking Therapeutics (VKTX) Gains Overweight Rating from Cantor F - GuruFocus
Why Viking Therapeutics Stock Popped Today - MSN
Viking Therapeutics (VKTX) Price Target Reduced Amid Competitive Obesity Market | VKTX Stock News - GuruFocus
Viking Therapeutics price target lowered to $75 from $95 at Truist - TipRanks
Decoding Viking Therapeutics Inc (VKTX): A Strategic SWOT Insigh - GuruFocus
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips - MSN
Viking Therapeutics targets 2025 Phase 3 trials for VK2735 obesity program with promising results - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Viking Therapeutics EPS Miss Overlooked as Long-Term Pipeline Gains Focus - Investing.com
Viking Therapeutics Stock May Struggle After As-Expected Report - MarketBeat
Viking Therapeutics, Inc. SEC 10-Q Report - TradingView
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025 - simplywall.st
Viking Therapeutics (VKTX) Price Target Reduced by B. Riley | VKTX Stock News - GuruFocus
Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ... - Yahoo Finance
Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising Expenses - GuruFocus
Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ... By GuruFocus - Investing.com Canada
Viking Therapeutics (VKTX) Eyes Takeover Amid Rumors - GuruFocus
Viking Therapeutics Advances Clinical Pipeline in Q1 2025 - TipRanks
자본화:
|
볼륨(24시간):